Angel Arenal
Overview
Explore the profile of Angel Arenal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carta-Bergaz A, Rios-Munoz G, Avila P, Atienza F, Gonzalez-Torrecilla E, Arenal A
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457545
Atrial fibrillation (AF), the most common arrhythmia, is associated with increased morbidity, mortality, and healthcare costs. Evidence indicates that rhythm control offers superior cardiovascular outcomes compared to rate control, especially...
2.
Bazan V, Arana E, Rubio-Campal J, Calvo D, Alvarez Acosta L, Hernandez Afonso J, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Sep;
77(12):1026-1036.
PMID: 39313188
Introduction And Objectives: We report the results of the 2023 Spanish catheter ablation registry. Methods: Procedural data were collected and incorporated into the REDCap platform by all participating centers through...
3.
Gonzalez-Casal D, Perez-Castellanos A, Flores N, Carta-Bergaz A, Gonzalez-Torrecilla E, Bruna Fernandez V, et al.
Pacing Clin Electrophysiol
. 2024 Feb;
47(3):383-391.
PMID: 38348921
Objective: The presence of cannon A waves, the so called "frog sign", has traditionally been considered diagnostic of atrioventricular nodal re-entrant tachycardia (AVNRT). Nevertheless, it has never been systematically evaluated....
4.
Centeno M, Alvarez Garcia-Roves R, Perez-Caballero R, Arenal A, Atienza F, Gonzalez-Torrecilla E, et al.
Rev Esp Cardiol (Engl Ed)
. 2023 Nov;
77(5):362-369.
PMID: 38000625
Introduction And Objectives: There is limited evidence regarding the use of subcutaneous implantable cardioverter-defibrillators (S-ICD) in pediatric patients. The aim of this study was to determine the incidence of complications...
5.
Carta-Bergaz A, Avila P, Arenal A
Rev Esp Cardiol (Engl Ed)
. 2023 Oct;
77(5):436.
PMID: 37816452
No abstract available.
6.
Avila P, Berruezo A, Jimenez-Candil J, Tercedor L, Calvo D, Arribas F, et al.
Europace
. 2023 Jun;
25(7).
PMID: 37366571
Background And Aims: Bayesian analyses can provide additional insights into the results of clinical trials, aiding in the decision-making process. We analysed the Substrate Ablation vs. Antiarrhythmic Drug Therapy for...
7.
Arenal A, Rios-Munoz G, Carta-Bergaz A, Ruiz-Hernandez P, Perez-David E, Crisostomo V, et al.
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555857
Clinical data suggest that cardiosphere-derived cells (CDCs) could modify post-infarction scar and ventricular remodeling and reduce the incidence of ventricular tachycardia (VT). This paper assesses the effect of CDCs on...
8.
Diez-Delhoyo F, Sanchez de la Nava A, Sanz-Ruiz R, Avila P, Gonzalez-Torrecilla E, Delgado-Montero A, et al.
J Cardiovasc Electrophysiol
. 2022 Sep;
33(12):2485-2495.
PMID: 36168873
Introduction: Ablation of atrial fibrillation (AF) is usually not considered in patients with rheumatic mitral stenosis (RMS). We analyzed the results of a combined procedure of AF ablation and percutaneous...
9.
Arenal A, Avila P
J Am Coll Cardiol
. 2022 Sep;
80(10):e79-e80.
PMID: 36049811
No abstract available.
10.
Sanchez de la Nava A, Gomez-Cid L, Rios-Munoz G, Fernandez-Santos M, Fernandez A, Arenal A, et al.
BioTech (Basel)
. 2022 Jul;
11(3).
PMID: 35892928
Translational science has been introduced as the nexus among the scientific and the clinical field, which allows researchers to provide and demonstrate that the evidence-based research can connect the gaps...